help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alvaro, V.
Right arrow Articles by Joubert, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alvaro, V.
Right arrow Articles by Joubert, D.

Journal of Clinical Endocrinology & Metabolism, Vol 77, 1125-1129, Copyright © 1993 by Endocrine Society


ARTICLES

Invasive human pituitary tumors express a point-mutated alpha-protein kinase-C

V Alvaro, L Levy, C Dubray, A Roche, F Peillon, B Querat and D Joubert
Centre CNRS-INSERM de Pharmacologie et d'Endocrinologie, Montpellier, France.

Protein kinase-C (PKC) is a ubiquitous eukaryotic kinase that plays a key role in transmembrane signaling and influences important cellular processes, such as proliferation. Increases in its activity and expression have been demonstrated in adenomatous human pituitaries, with protein expression being the highest in invasive tumors (1). Moreover, in these same invasive tumors, the mean increase in expression (8.9-fold) does not correlate with the mean increase in activity (2.6-fold), suggesting a dysfunction in PKC in these tumors. Here, we show that the PKC alpha-isoform (alpha PKC) is overexpressed in human pituitary tumors. The complete sequencing of the PKC cDNA from four invasive tumors has revealed a point mutation that is absent in the noninvasive tumors analyzed. The point mutation is located at position 294 of the protein, in the V3 region, leading to a substitution of a negatively charged aspartic acid by an apolar glycine. Thus, not only is alpha PKC overexpressed in human pituitary tumors, but it is also structurally altered in the invasive subpopulation of these tumors.


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
B. Diouf, A. Collazos, G. Labesse, F. Macari, A. Choquet, P. Clair, C. Gauthier-Rouviere, N. C. Guerineau, P. Jay, F. Hollande, et al.
A 20-Amino Acid Module of Protein Kinase C{epsilon} Involved in Translocation and Selective Targeting at Cell-Cell Contacts
J. Biol. Chem., July 10, 2009; 284(28): 18808 - 18815.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
S. A. Boikos and C. A. Stratakis
Molecular genetics of the cAMP-dependent protein kinase pathway and of sporadic pituitary tumorigenesis
Hum. Mol. Genet., April 15, 2007; 16(R1): R80 - R87.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
I. M. Hussaini, C. Trotter, Y. Zhao, R. Abdel-Fattah, S. Amos, A. Xiao, C. U. Agi, G. T. Redpath, Z. Fang, G. K.K. Leung, et al.
Matrix Metalloproteinase-9 Is Differentially Expressed in Nonfunctioning Invasive and Noninvasive Pituitary Adenomas and Increases Invasion in Human Pituitary Adenoma Cell Line
Am. J. Pathol., January 1, 2007; 170(1): 356 - 365.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
A. Collazos, B. Diouf, N. C. Guerineau, C. Quittau-Prevostel, M. Peter, F. Coudane, F. Hollande, and D. Joubert
A Spatiotemporally Coordinated Cascade of Protein Kinase C Activation Controls Isoform-Selective Translocation.
Mol. Cell. Biol., March 1, 2006; 26(6): 2247 - 2261.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Hara, Y. Saito, T. Hirai, K. Nakamura, K. Nakao, M. Katsuki, and K. Chida
Deficiency of Protein Kinase C{alpha} in Mice Results in Impairment of Epidermal Hyperplasia and Enhancement of Tumor Formation in Two-Stage Skin Carcinogenesis
Cancer Res., August 15, 2005; 65(16): 7356 - 7362.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Zhu, Q. Dong, B. J. Tan, W. G. Lim, S. Zhou, and W. Duan
The PKC{alpha}-D294G Mutant Found in Pituitary and Thyroid Tumors Fails to Transduce Extracellular Signals
Cancer Res., June 1, 2005; 65(11): 4520 - 4524.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
C. Quittau-Prevostel, N. Delaunay, A. Collazos, A. Vallentin, and D. Joubert
Targeting of PKC{alpha} and {epsilon} in the pituitary: a highly regulated mechanism involving a GD(E)E motif of the V3 region
J. Cell Sci., January 1, 2004; 117(1): 63 - 72.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
A. Lania, G. Mantovani, and A. Spada
Genetics of Pituitary Tumors: Focus on G-Protein Mutations
Experimental Biology and Medicine, October 1, 2003; 228(9): 1004 - 1017.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
V. A. Adarichev, R. Vaiskunaite, J. Niu, I. V. Balyasnikova, and T. A. Voyno-Yasenetskaya
G{alpha}13-mediated transformation and apoptosis are permissively dependent on basal ERK activity
Am J Physiol Cell Physiol, October 1, 2003; 285(4): C922 - C934.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. A. Knauf, L. S. Ward, Y. E. Nikiforov, M. Nikiforova, E. Puxeddu, M. Medvedovic, T. Liron, D. Mochly-Rosen, and J. A. Fagin
Isozyme-Specific Abnormalities of PKC in Thyroid Cancer: Evidence for Post-Transcriptional Changes in PKC Epsilon
J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2150 - 2159.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
I. Eude, E. Dallot, F. Ferre, and M. Breuiller-Fouche
Protein Kinase C{alpha} Is Required for Endothelin-1-Induced Proliferation of Human Myometrial Cells
Biol Reprod, January 1, 2002; 66(1): 44 - 49.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
A. Vallentin, T.-C. Lo, and D. Joubert
A Single Point Mutation in the V3 Region Affects Protein Kinase C{alpha} Targeting and Accumulation at Cell-Cell Contacts
Mol. Cell. Biol., May 15, 2001; 21(10): 3351 - 3363.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Xu, T. Sano, S. Yamada, C. C. Li, and M. Hirokawa
Expression of Corticotropin-Releasing Hormone Messenger Ribonucleic Acid in Human Pituitary Corticotroph Adenomas Associated with Proliferative Potential
J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1220 - 1225.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
P. L. M. Dahia and A. B. Grossman
The Molecular Pathogenesis of Corticotroph Tumors
Endocr. Rev., April 1, 1999; 20(2): 136 - 155.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
S. L. Asa and S. Ezzat
The Cytogenesis and Pathogenesis of Pituitary Adenomas
Endocr. Rev., December 1, 1998; 19(6): 798 - 827.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
S. J. Hurel, P. E. Harris, A. M. McNicol, S. Foster, W. F. Kelly, and P. H. Baylis
Metastatic Prolactinoma: Effect of Octreotide, Cabergoline, Carboplatin and Etoposide; Immunocytochemical Analysis of Proto-Oncogene Expression
J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 2962 - 2965.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. A. A. Abbass, S. L. Asa, and S. Ezzat
Altered Expression of Fibroblast Growth Factor Receptors in Human Pituitary Adenomas
J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1160 - 1166.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1993 by The Endocrine Society